DEER PARK, Ill. – September 28, 2026 – Leica Biosystems, a Danaher company (the “Company”) and a global leader in digital and anatomic pathology solutions advancing precision cancer diagnostics, announced today that the Company has completed its acquisition of privately held StatLab Medical Products (“StatLab”), a leading provider of pre-analytical consumables and equipment, from Linden Capital Partners and Audax Private Equity. For patients and their care teams, precision cancer diagnostics can provide critical information about the type and characteristics of the disease, helping inform more personalized treatment decisions.